2026抗體藥物暨第21屆前瞻生醫新知研討會

Dear distinguished guests, ladies and gentlemen,

 

On behalf of the organizing committee, it is my great pleasure to welcome you to the 21st Antibody Therapeutic Conference (ATC) – the 2026 Antibody Therapeutics Conference: Extended Applications of Antibodies. The conference will be held on May 26–27, 2026, at the National Biotechnology Research Park in Taipei, Taiwan.

 

In recent years, the field of antibody therapeutics has continued to experience remarkable growth, particularly in the treatment of cancer, immune-mediated diseases, and infectious diseases. Advances in antibody engineering have led to the rapid development of next-generation modalities, including bispecific antibodies, antibody-drug conjugates (ADCs), and T-cell–engaging therapies.

 

These innovative immunotherapies—ranging from checkpoint blockade and ADCs to chimeric antigen receptor T-cell (CAR-T) therapies—are transforming the landscape of modern medicine and offering new hope for patients with previously difficult-to-treat diseases.

 

This year, ATC will continue to showcase a broad spectrum of remarkable achievements, with a focus on the extended applications of antibodies and emerging therapeutic modalities for the treatment of human diseases. We aim to provide a platform for participants to connect, communicate, gain new knowledge, and discuss the latest advances in this rapidly evolving field.

 

The Taiwan Antibody Association (TAA), the organizer of ATC, was established in 2012 with the mission of facilitating research and industrial development of antibody therapeutics and related technologies in Taiwan. By hosting international conferences such as ATC, we hope to promote the exchange of ideas and foster collaborations between senior experts and young scientists from around the world.

 

We sincerely hope that this conference will be informative and inspiring, and that it will encourage meaningful contributions to the advancement of antibody therapeutics. Once again, we thank you for joining us and wish you a productive and enjoyable conference.

 

會議時間 : 2026年5月26日(二)至27日(三)

會議地點 : 國家生技研究園區 C201國際會議廳

報名網址 : https://www.accupass.com/go/ATC2026

官網 : https://antibody.org.tw/atc2026/

 

● 會員免費、本次活動之主辦、協辦、贊助單位之同仁可免費參加

● 團體會員：生物技術開發中心(DCB)、台灣醣聯、基亞生物科技、生達化學製藥、台康生技、進階生物科技、智合精準醫學科技、免疫功坊、國光生物科技、永昕生物醫藥、安肽生醫科技、台灣永生細胞、凌越生醫、臺灣生物醫藥製造(TBMC)

● 非會員：1,000元

● 現在加入會員一年只要1,000元